Digital newsroom

December 12, 2019

New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-Negative or Node-Positive Early-Stage Breast Cancer

December 5, 2019

Dr. David Ahlquist, Co-Inventor of Cologuard, Named a Fellow of the National Academy of Inventors

November 8, 2019

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

November 8, 2019

Exact Sciences Presents Data on Blood-based Test for Detection of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation

October 29, 2019

Exact Sciences Presents New Stool-based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study

September 24, 2019

PGA Tour Champions and Exact Sciences Announce Five-year Extension of Cologuard Classic

September 23, 2019

Cologuard® Gains FDA Approval for Use in Younger Americans, Ages 45 to 49

September 19, 2019

Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work and Fortune

September 10, 2019

Cologuard® Helps More People Get Screened In A Cost-Effective Way

July 29, 2019

Exact Sciences And Genomic Health To Combine, Creating Leading Global Cancer Diagnostics Company

July 17, 2019

Exact Sciences Designated a Great Place to Work-Certified™ Company in 2019

June 26, 2019

Exact Sciences Advances Fight Against Colorectal Cancer with Opening of New Laboratory

1 2 3 4 5 6 7 8 9

Multimedia

Videos Photos

Leading the battle against cancer, together.

Exact Sciences and Genomic Health have teamed up to take cancer on, together. By combining our leading portfolio of products, we are continuing our relentless pursuit of earlier detection and smarter answers.

Read the official announcementLearn more About Us